{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T23:10:23Z","timestamp":1758409823417,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jss.2019.11.015","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T05:48:24Z","timestamp":1576734504000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Variable Benefits of Antibody Induction by Kidney Allograft Type"],"prefix":"10.1016","volume":"248","author":[{"given":"Aaron M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranganath G.","family":"Kathawate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Woodside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall S.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","key":"10.1016\/j.jss.2019.11.015_bib1"},{"key":"10.1016\/j.jss.2019.11.015_bib2","unstructured":"2006 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI."},{"key":"10.1016\/j.jss.2019.11.015_bib3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/01.tp.0000287118.76725.c1","article-title":"Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys","volume":"84","author":"Sung","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jss.2019.11.015_bib4","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.transproceed.2005.09.118","article-title":"Expanded criteria donors for kidney transplantation","volume":"37","author":"Merion","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jss.2019.11.015_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1681\/ASN.V123589","article-title":"Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates","volume":"12","author":"Ojo","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jss.2019.11.015_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1600-6143.3.s4.11.x","article-title":"Expanded criteria donors for kidney transplantation","volume":"3","author":"Metzger","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5500\/wjt.v3.i4.68","article-title":"Novel immunosuppressive agents in kidney transplantation","volume":"3","author":"Hardinger","year":"2013","journal-title":"World J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/ctr.12768","article-title":"High mortality in diabetic recipients of high KDPI deceased donor kidneys","volume":"30","author":"Pelletier","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/TP.0000000000001310","article-title":"Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States","volume":"101","author":"Gharibi","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jss.2019.11.015_bib10","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/ajt.12210","article-title":"Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation","volume":"13","author":"Cavaill\u00e9-Coll","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","article-title":"Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment","volume":"5","author":"Salvadori","year":"2015","journal-title":"World J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib12","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/01.ASN.0000093254.31868.85","article-title":"Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients","volume":"14","author":"Irish","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jss.2019.11.015_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2146\/ajhp090636","article-title":"Induction immunosuppressive therapies in renal transplantation","volume":"68","author":"Gabardi","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jss.2019.11.015_bib14","first-page":"367","article-title":"Induction immunosuppression in high-risk kidney transplant recipients","volume":"14","author":"Buttigieg","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib15","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/ajt.13191","article-title":"Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: five-year follow-up of a randomized study","volume":"15","author":"Hellemans","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal\u00a0transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jss.2019.11.015_bib17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1600-6143.2006.01275.x","article-title":"SRTR center-specific reporting tools: posttransplant outcomes","volume":"6","author":"Dickinson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/aje\/kwf095","article-title":"Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates","volume":"156","author":"Johnston","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jss.2019.11.015_bib19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00007890-200211150-00014","article-title":"Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors","volume":"74","author":"Port","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jss.2019.11.015_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jss.2019.11.015_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trre.2015.09.002","article-title":"Do elderly recipients really benefit from kidney transplantation?","volume":"29","author":"Hellemans","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.jss.2019.11.015_bib22","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.transproceed.2019.02.061","article-title":"Effectiveness of thymoglobulin induction therapy in kidney transplant from deceased donor with mild to moderate acute kidney injury","volume":"51","author":"Lee","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jss.2019.11.015_bib23","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/ajt.15355","article-title":"Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States","volume":"19","author":"Bowring","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2019.11.015_bib24","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2012.04146.x","article-title":"Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors","volume":"12","author":"Woodside","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480419308091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480419308091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:46:03Z","timestamp":1758379563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480419308091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"alternative-id":["S0022480419308091"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2019.11.015","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable Benefits of Antibody Induction by Kidney Allograft Type","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2019.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}